A three-pronged approach was followed for deducing the medical imaging market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for medical imaging market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of medical imaging market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The medical imaging market was categorized into four segments, namely product (X-ray Devices, Ultrasound, Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging), end-use (Hospitals, Diagnostic Imaging Centers), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
The medical imaging market was segmented into product, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The medical imaging market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S., Canada, the UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, South Korea, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The medical imaging market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
GE HealthCare - It is a global pharmaceutical diagnostics, medical technology, and digital solutions company. The company operates in imaging, ultrasound, pharmaceutical diagnostics, and patient care solutions. The ultrasound segment includes diagnosis, screening, monitoring of multiple diseases, and therapy support. The pharmaceutical diagnostics segment includes diagnostic imaging agents, which are used to enhance nuclear medicine procedures and radiology across pathways.
Siemens Healthcare GmbH - Siemens Healthcare GmbH is a well-known producer and supplier of medical diagnostics equipment. The company's major divisions are energy, health services (Siemens Healthineers), and infrastructure & cities.
Koninklijke Philips N.V. - The three primary divisions of the company are personal health, integrated care, and diagnostics. It expanded as an ambulatory care provider that offers optimal patient care.
CANON MEDICAL SYSTEMS CORPORATION - The medical system business unit of the company offers CT scan systems, ultrasound devices, diagnostic X-ray devices, magnetic resonance devices, clinical chemistry analyzers, radiology systems, and ophthalmology tools.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. - It is a manufacturer of medical equipment & accessories for human and veterinary use. The company's business is categorized into three domains: patient monitoring & life support, in vitro diagnostic products, and medical imaging systems. It exhibits a global R&D, marketing, and service network. Currently, the company's products and services are available in 190+ countries and regions globally. In China, its products and solutions can be found in nearly 110,000 medical institutions and 99% of Class A tertiary hospitals.
Esaote SpA - Esaote SpA is an Italy-based company serving the biomedical sector and offers the designing, production, sales, and maintenance of equipment used for medical diagnostics. It provides medical imaging solutions such as dedicated MRI and ultrasound. The medical imaging solutions are complemented by technical service, healthcare IT, and interventional ultrasound products through broad clinical offerings. The company has its industrial & research units in Italy & the Netherlands.
Samsung Medison Co., Ltd. - Samsung Medison Co, Ltd is an affiliate of Samsung Electronics. The company manufactures diagnostic ultrasound systems across the world in various medical fields. The company's products are integrated with IT, semiconductors, and image processing & communication technologies in ultrasound systems. Based on high image quality & good usability, the company offers certain hybrid systems, which meet the clinical needs of various users. The company has a U.S. subsidiary, NeuroLogica Corp.
Shimadzu Corporation - Shimadzu Corporation is a public company based in Japan. The company manufactures medical equipment and precision instruments. The product segments of the company include analytical instruments, aircraft equipment, medical instruments, industrial machinery equipment, testing, and measuring instruments. A broad range of the company’s medical imaging solutions is covered under the medical equipment segment.
Carestream Health - Carestream Health is a multinational company involved in the manufacture and distribution of diagnostic imaging devices for imaging modalities used in medical imaging procedures. The company manufactures medical diagnostic equipment, including radiology imaging machines. It develops healthcare technology solutions for medical imaging and diagnostics.
Shanghai United Imaging Healthcare Co., Ltd. - It is a member of the United Imaging Group and develops & produces high-performance advanced medical imaging systems, radiotherapy equipment, and life sciences instruments. The company offers intelligent digital solutions to customers around the globe. The company’s products are installed in more than 11,100 medical & research institutes and nearly 1,000 top hospitals in 59 countries, including the U.S. & Japan.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member